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CCR2þCD103 intestinal dendritic cells develop
from DC-committed precursors and induce
interleukin-17 production by T cells
CL Scott1,2, CC Bain1, PB Wright1, D Sichien2, K Kotarsky3, EK Persson3, K Luda3, M Guilliams2,
BN Lambrecht2, WW Agace3,4, SWF Milling1 and AM Mowat1
The identification of intestinal macrophages (m/s) and dendritic cells (DCs) is a matter of intense debate. Although
CD103þ mononuclear phagocytes (MPs) appear to be genuine DCs, the nature and origins of CD103 MPs remain
controversial. We show here that intestinal CD103CD11bþ MPs can be separated clearly into DCs andm/s based on
phenotype, gene profile, and kinetics. CD64CD103CD11bþ MPs are classical DCs, being derived from Flt3
ligand-dependent, DC-committed precursors, not Ly6Chi monocytes. Surprisingly, a significant proportion of these
CD103CD11bþ DCs express CCR2 and there is a selective decrease in CD103CD11bþ DCs in mice lacking this
chemokine receptor. CCR2þCD103 DCs are present in both themurine and human intestine, drive interleukin (IL)-17a
productionbyTcells in vitro, andshowconstitutive expressionof IL-12/IL-23p40. Thesedatahighlight theheterogeneity
of intestinal DCs and reveal a bona fide population of CCR2þ DCs that is involved in priming mucosal T helper type 17
(Th17) responses.
INTRODUCTION
The intestine is constantly exposed tomany antigens and innate
immune stimuli, including dietary constituents, commensal
bacteria, and pathogens.1 The intestinal immune system must
discriminate between these different agents, mounting protec-
tive immunity against pathogens, but developing active tolerance
to harmless materials. If this process fails, inappropriate
responses can lead to inflammatory bowel diseases and celiac
disease. Mononuclear phagocytes (MPs) in the lamina propria
(LP) such as dendritic cells (DCs) and macrophages (mfs) are
central to these events, serving distinct, yet complementary
functions. Whereas DCs migrate to draining lymph nodes and
prime naive T cells,2–5 mfs are sessile phagocytes that scavenge
bacteria and damaged cells. They also maintain the expansion
of antigen-specific regulatory T cells through the production
of interleukin-10 (IL-10)6,7 and promote epithelial barrier
integrity.8
Because of their distinct functions, it is likely that mucosal
DCs andmfs play different roles in disease, meaning they need
to be characterized as precisely as possible. However, this has
been the source of much confusion and controversy,4,9–14
largely because many of the phenotypic markers used to
discriminate DCs and mfs are insufficiently specific. Initial
studies defined intestinal DCs simply on the basis of CD11c and
major histocompatibility complex II (MHCII) coexpression,
but most if not all mfs in the mucosa also express these
markers.3,10,13,15,16 More recent work has used CD103, CD11b,
and CX3CR1 expression to identify three major populations of
CD11cþMHCIIþ MPs. Two of these express CD103, lack
CX3CR1, and are either CD11bþ or CD11b .3,5,17,18 Based on
their derivation fromDC-committed precursors (pre-DCs) and
genetic profiles, it is generally agreed that these CD103þ MPs
are bona fide DCs.11,19,20 The third population of CD103
CD11bþ MPs is less well understood. Although they express
CX3CR1,5,16,21 and were originally considered to bemonocyte-
derived DCs,19,20 recent transcriptional analyses suggest they
are more similar to mfs than DCs.9,11 However, we recently
identified CD103CD11bþCX3CR1int cells migrating in
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pseudoafferent lymph that are bona fide CD103 DCs, based
on their responsiveness to Flt3 ligand (Flt3L) and lack of mf
markers such as F4/80 or CD64 ( ref. 5 and our unpublished
observations). Although analogous cells have been described in
steady-state LP,5,16,22,23 confusion remains over the relative
contribution of DCs and mfs to the CD103CD11bþ LP
population and their developmental origin remains conten-
tious. In previous work, we found that Ly6Chi monocytes could
not generate CD103þ or CD103 subsets of bona fide DCs in
steady-state colon.16,24 However, amore recent study suggested
that CD103 DCs in themucosa are indeedmonocyte derived,
on the basis that their accumulation and/or development
involves a CCR2-dependent precursor.23
Here, we identify a population of genuine CD103 DCs in
the LP that are phenotypically, genetically, and kinetically
distinct frommfs. Similar to their CD103þ counterparts, these
CD103 DCs arise from Flt3L-dependent, DC-committed
precursors and not from Ly6chi monocytes. Significantly, we
also demonstrate the presence of CCR2-expressing CD103
CD11bþ DCs in themurine and humanLP that have a selective
ability to prime IL-17a-producing CD4þ T cells in vitro. The
existence of this novel subset of bona fideDCsmay help explain
previous conflicting results and provide insights into functional
compartmentalization among mucosal DC populations.
RESULTS
Expression of F4/80 and CD64 defines two distinct
CD103CD11bþ mononuclear phagocyte populations in
intestinal LP
To begin to determine the origins of CD103 MPs in the small
intestinal (SI) LP, we first set out to establish a gating strategy
that would allow accurate discrimination between CD103
DCs andmfs. After first identifying intestinalMPs as CD11cþ
MHCIIþ cells among live leukocytes, we found three discrete
populations based onCD103 andCD11b expression; amajority
population of CD103CD11bþ cells, together with smaller
numbers of CD103þCD11bþ and CD103þCD11b cells
(Figure 1a). A small population of CD103CD11b cells was
also identified, but as these may derive from isolated lymphoid
follicles, rather than the LP itself,5 we did not examine them
further. To distinguish between DCs and mfs, MPs were next
examined for expression of the pan-mfmarker F4/80, together
with CD64 that has recently been described to be specific for
mfs in the intestine.16,24 Consistent with the general consensus
that CD103þ MPs are classical DCs,3,4,18–20,25 none of the
CD103þ MPs expressed either F4/80 or CD64 (Figure 1a).
In contrast, the CD11cþMHCIIþCD103CD11bþ cells
were heterogeneous. Although B85% of this population
were F4/80þCD64þ mfs, the remainder were entirely nega-
tive for both CD64 and F4/80, suggesting they may be DCs
(Figure 1a,b). Identical subsets of CD64þ and CD64 MPs
were present in steady-state colonic LP, although in different
proportions, with the CD103þCD11b and CD103CD11bþ
subsets both outnumbering the CD103þCD11bþ DCs in this
tissue (Supplementary Figure S1a-c online). Interestingly,
there was an inverse correlation between the proportions of
CD103þCD11bþ DCs and CD64þ mfs throughout the
length of the small and large intestine, whereas the proportions
of the other DC subsets were not significantly different between
the various segments of the small intestine, before increasing in
the colon (Supplementary Figure S1b,c). All CD64 subsets
could also be identified among migratory CD11cþMHCIIhi
MPs in the steady-state mesenteric lymph nodes (MLNs),
whereas CD64þ MPs were virtually absent (Supplementary
Figure S1d,e).
CD64CD103CD11bþ MPs are bona fide DCs
To clarify further the nature of the CD103CD11bþ cells, we
examined other features that define DCs and mfs. Unlike
the CD64þ mfs, all subsets of CD64 MPs, including the
CD103CD11bþ cells, expressed mRNA for the DC-specific
transcription factor Zbtb46 (Figure 1c)26,27 and were not
phagocytic as assessed by the ability to take up bacterial
particles into acidified vesicles (Figure 1d). Whereas all the
CD64þF4/80þCD103CD11bþ mfs expressed the mf-
specific markers MerTK and CD14,9,11 the CD64F4/80
CD103CD11bþ MPs lacked expression of these markers, as
did the prototypic CD103þ DCs. Conversely, CD64F4/80
CD103CD11bþ MPs expressed the recently defined DC-
specific markers CD26 and CD272, whereas CD64þF4/80þ
CD103CD11bþ MPs did not (Figure 1e). Consistent with
previous studies,3,16,18,21,24,28 CX3CR1 was expressed at high or
intermediate levels on CD64þF4/80þCD103CD11bþ mfs,
but was absent from CD103þ DCs (Figure 1e). However,
the CD64CD103CD11bþ MPs within the mucosa all
expressed intermediate levels of CX3CR1 (Figure 1e), con-
sistent with the CD103CD11bþ DCs we identified recently
in pseudoafferent intestinal lymph.5
Finally, we examined the dependence of the different
MP subsets on the DC-specific growth factor Flt3L.29,30 As
expected, normal numbers of CD11cþCD64þ mfs were pre-
sent in the intestine of Flt3L / mice (Figure 1f). In contrast,
all CD11cþCD64 subsets including the CD64CD103
CD11bþ MPs were dramatically reduced in the LP of Flt3L /
mice compared with wild-type (WT) controls (Figure 1f).
Taken together, these data confirm the presence of bona fide
CD103CD11bþ DCs in the steady-state LP.
Intestinal DCs divide in situ and turn over rapidly in the
steady state
Previous work has shown that intestinal mfs and CD103þ
DCs have distinct population dynamics in vivo.3,18 However,
these studies considered all CD103CD11bþ MPs to be mfs.
Having now identified bona fide CD103CD11bþ DCs in LP,
we used 5-bromodeoxyuridine (BrdU) pulsing to determine
their population dynamics compared with mfs and CD103þ
DCs in vivo.
To examine this, BrdU was administered continuously for 3
days and its incorporation was assessed immediately after its
withdrawal and again 9 days thereafter. After 3 days of BrdU
feeding, a substantial majority (70–85%) of both subsets of
CD103þ DCs was BrdUþ , whereas only 15–25% of CD64þ
mfs had been labeled at this time (Figure 1g). Importantly,
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CD103CD11bþ DCs displayed BrdU labeling identical to the
CD103þ DC subsets and very distinct from CD64þ mfs
(Figure 1g). At 9 days after BrdUwithdrawal, the proportion of
BrdUþ cells among all CD64 DC subsets had decreased to
o10%, whereas the proportion of BrdUþ CD64þ mfs
remained steady, indicating relative longevity compared with
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Figure 1 CD64CD103CD11bþ intestinal mononuclear phagocytes (MPs) are bona fide dendritic cells (DCs). (a) Intestinal MPs were defined as
CD11cþMHCIIþ cells among live CD45þ lamina propria cells, analyzed for CD103 and CD11b expression, and the resulting populations of MP were
examined for CD64 and F4/80 expression. (b) Proportions of MP populations among total CD11cþMHCIIþ cells. Data are representative of at least 15
independent experiments with n¼ 3/4 per experiment. (c) Small intestinal lamina propria (SI LP) MP populations were fluorescence-activated cell sorter
(FACS)-purified and Zbtb46 expression assessed by real-time PCR. The results shown are expressed relative to HPRT using the 2DDct method with
macrophages (mfs) set to 1 and are pooled from2 independent experimentswith cells pooled from9 to 12mice on each occasion. (d) Total SI LPdigests
were incubated at 37 1Cor 4 1Cwith pHrodoEscherichia coli bioparticles for 15min and assessed for phagocytic ability. Bar chart showsmeanDMFI (MFI
37 1C–MFI 4 1C)þ1 s.d., n¼ 4.MFI,mean fluorescence intensity. ***Po0.001 vs.mfs, one-way analysis of variance (ANOVA) with Bonferroni posttest.
(e)Expression ofCD272,CD26,MerTK,CD14, andCX3CR1onSI LPMPpopulations (colored) comparedwithappropriate background controls (shaded
gray). (f) Populations of SI LP MP as a proportion of total live leukocytes in wild-type (WT) and Flt3L / mice. Data are pooled from two independent
experiments. ***Po0.005, Student’s t-test. (g, h) Mice received one injection of 1mgml 1 5-bromodeoxyuridine (BrdU) intraperitoneally (i.p.), followed
by 0.8mgml1 BrdU in the drinking water for 3 days, before being returned to normal drinking water. Mice were culled immediately following cessation of
BrdU feeding, or 3 or 9 days later andMPsubsets identified in (g) SI LPand amongmigratoryDCs in the (h)mesenteric lymph nodes (MLNs). Data are the
proportions of BrdUþ cells among each subset and are representative of two independent experiments with n¼ 3/4 per time point. Black asterisks
represent significant differences between D3 and D3þ9 for all DC populations, whereas colored asterisks represent significant differences between D3
and D3þ3 in MLNs. ***Po0.001, **Po0.01, *Po0.05 Student’s t-test. NS, nonsignificant.
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DCs (Figure 1g). In contrast to LP, where maximal BrdU
labeling was achieved upon BrdUwithdrawal at day 3, only 30–
50% of the CD64CD103þ and CD103 populations among
the CD11cþMHCIIhi migratory cells in MLNs were BrdUþ at
this time (Figure 1h). The frequency of BrdUþ cells among
migratory DCs in the MLNs increased further 72 h after BrdU
withdrawal, consistent with migration of BrdUþ cells from the
LP. Consistent with the short lifespan of DCs, only 15–20% of
MLN DCs remained BrdUþ 9 days after BrdUþ withdrawal.
Resident CD11cþMHCIIint DCs in MLNs had a distinct BrdU
profile, achieving maximal labeling before withdrawal of BrdU
(data not shown).
CD103CD11bþ intestinal DCs arise from committed DC
precursors
Previous studies that did not take the heterogeneity of CD103
CD11bþ MPs into account suggested that they were derived
exclusively from Ly6Chi monocytes.19,20,31 Thus, we next
investigated the origin of the bona fide CD103CD11bþ
DCs, first by adoptive transfer of Ly6Chi monocytes from
CX3CR1þ /gfp mice into monocytopenic CCR2 / mice
(Supplementary Figure S2a,b). At 5 days after transfer,
donor Ly6Chi monocytes and their progeny could be identified
in the SI LP by their expression of CD45.1 and CX3CR1-GFP.
At this time, all donor cells were CD11cþMHCIIþF4/80þ ,
with none being found within the CD11cþF4/80 DC gate
(Figure 2a). Furthermore, no progeny of transferred Ly6Chi
monocytes could be found in the MLNs (data not shown).
Thus, in our hands, Ly6Chi monocytes cannot act as pro-
genitors for rigorously defined CD103 DCs in the steady-
state intestine, nor can monocyte-derived MPs migrate to the
MLNs from the LP under these conditions.
Given their independence from monocytes, we next tested
whether CD103CD11bþ DCs were derived from committed
pre-DCs,32–34 as has been shown for mucosal CD103þ
DCs.19,20 Pre-DCs from bone marrow (LinCD11cintCCR9
B220CD135þSIRPaintCD117 ; Supplementary Figure
S2b,c) were fluorescence-activated cell sorter (FACS)-
purified from CD45.2þ mice that had received B16 tumors
secreting Flt3L 10 days earlier, labeled with CellTrace Violet
dye, and transferred into unmanipulated, steady-state, con-
genic CD45.1þ recipients. Donor-derived cells could already
be found in the LP 24 h after transfer, at which time most had
begun to upregulate both MHCII and CD11c (Supplementary
Figure S2d,e). The expression of both these markers then
increased progressively until their levels became equivalent to
those on endogenous DCs. By 5 days after transfer, most donor
cells had acquired MHCII expression and upregulated
CD11c, but remained F4/80 , consistent with them being
DCs (Figure 2b and Supplementary Figure S2d,e). The trans-
ferred pre-DCs not only gave rise to both CD103þCD11b
and CD103þCD11bþ DC populations in LP, but there was
also a clear population of CD103CD11bþ donor-derived
cells that lacked F4/80 expression, demonstrating directly that
pre-DC can give rise to CD103CD11bþ DCs (Figure 2c,d).
Donor pre-DCs also gave rise to all three DC populations
among CD11cþMHCIIhi migratory DCs in the MLNs, as well
as in the colonic LP (data not shown).
CD103CD11bþ DCs are partially dependent on CCR2
Our results indicate that CD64CD103CD11bþ intestinal
MPs are DCs and are distinct from monocyte-derived mfs.
However, a recent study has identified a similar population of
CX3CR1intCD11cþMHCIIþ MPs in inflamed mucosa that
were characterized as monocyte-derived DCs on the basis of
their expression of Zbtb46 and CCR2 dependence.23 On this
basis it was concluded that some CD103 DCs differentiate
from monocytes that require CCR2 for their egress from the
bone marrow (BM).35 Therefore, we examined whether
deletion of CCR2 affected the abundance of our DC subsets
in the steady-state mucosa. Compared with WT controls,
CCR2 / mice had normal proportions and absolute numbers
of CD103þ DCs. However, they had a significant reduction in
CD64CD103CD11bþ DCs in the SI LP, and this was
mirrored by a reduction in the CD103 subset of CD11cþ
MHCIIhi migratory DCs in the MLNs (Figure 3a,b). A small
reduction in the number of CD103þCD11b DCs was also
observed among migratory DCs in the MLNs (Figure 3b). The
selective CCR2 dependence of CD103CD11bþ DCs and
CD64þ mfs was cell intrinsic, as it was replicated when these
populations were derived fromCCR2 / precursors in CD45.1
WT:CD45.2 CCR2 / mixed BM (Figure 3c). Whereas WT
and CCR2 / BMhad a roughly equivalent ability to populate
the CD103þ subsets of DCs, comparable with CCR2-indepen-
dent eosinophils, the repopulation of CD103CD11bþ DCs
was biased toward WT BM, with a WT:CCR2 / ratio ofB3
(Figure 3c,d). Similar results were observed for CD103
CD11bþ DCs among migratory DCs in the MLNs of chimeric
mice (Figure 3d). Consistent with their dependence on
replenishment by CCR2-dependent Ly6Chi monocytes in
the steady state,16,24 there was a substantial reduction in the
numbers of CD64þ mfs inCCR2 / LP and virtually allmfs
in the LP of the mixed chimeras were of WT origin, similar to
the pattern seen with blood Ly6Chi monocytes (Figure 3a,d).
Two populations of CD103CD11bþ intestinal DCs can be
defined by CCR2 expression
We reasoned that this partial dependence on CCR2 could
reflect heterogeneity among the CD103CD11bþ subset of
DCs and therefore analyzed CCR2 expression by the DC
subsets in SI LP. Whereas CD103þ DCs were mainly CCR2 ,
there were two clear populations of CD103CD11bþ DCs,
with the majority (B75–85%) being CCR2 and a smaller but
distinct fraction being CCR2þ (Figure 4a). Because of this
heterogeneity, we thought it important to examine whether
pre-DCs could give rise to both CCR2 and CCR2þ
CD103CD11bþ DCs, which had been investigated as a
single population in our earlier analyses. As with the endo-
genous population, CD103CD11bþ DCs derived from
transferred pre-DCs were heterogeneous for CCR2 expres-
sion 5 days after transfer, confirming that the CCR2þ DCs
were derived from pre-DCs (Figure 4b). FACS-purified
CCR2þCD103CD11bþ DCs also expressed mRNA for
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Zbtb46 and Flt3 at levels equivalent to CD103þ DCs and their
CCR2CD103 DC counterparts, confirming their DC
lineage (Figure 4c). Furthermore, both the CCR2 and
CCR2þ subsets of CD103CD11bþ DCs in the LP
expressed mRNA for CCR7 at similar levels to CD103þ
DCs, showing they have the potential to migrate out of the
mucosa to the MLNs (Figure 4c). Consistent with this,
CCR2þCD103CD11bþ DCs could be identified among
migratory DCs in the steady-state MLNs (Figure 4d).
CCR2þ and CCR2 CD103CD11bþ intestinal DCs are
functionally distinct
Having identified two distinct populations of CD103
CD11bþ DCs based on their expression of CCR2, we next
sought to determine the functional consequences of this
heterogeneity. Thus, SI LP DC subsets were FACS-purified,
pulsed with ovalbumin protein, and cocultured with carboxy-
fluorescein succinimidyl ester-labeled, ovalbumin-specific
T-cell receptor transgenic naive CD4þ T cells. All DC subsets,
including the CCR2þ and CCR2 populations of CD103
CD11bþ DCs, induced similar levels of OTII T-cell prolifera-
tion, as assessed by carboxyfluorescein succinimidyl ester
dilution (Figure 5a–c). The two subsets of CD103þ DCs
generated regulatory T cells in vitro as determined by
intracellular expression of FoxP3 (forkhead box P3) and
this appeared to be somewhat more efficient than either of the
CCR2þ and CCR2 subsets of CD103CD11bþ DCs that
had similar activity (Figure 5a). CD103þCD11b DCs
induced the differentiation of considerably more interferon-
g-producing CD4þ T cells than all other DC subsets; there
were no differences between the CD103þCD11bþ DCs
and the CCR2þ or CCR2 subsets of CD103CD11bþ
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Figure 3 Partial dependence of CD103CD11bþ lamina propria (LP) dendritic cells (DCs) on CCR2. (a) Small intestinal (SI) LP DCs from CCR2 /
and wild-type (WT) mice were examined for expression of CD103 and CD11b, with the numbers representing the frequency of each population as a
percentageof total CD11cþMHCIIþCD64 DCs.MHCII,major histocompatibility complex II. Scatter plot showsabsolute numbersof eachmononuclear
phagocyte (MP) population in SI LP of CCR2 / and WT mice. (b) Migratory (Mig.) mesenteric lymph node (MLN) DCs from CCR2 / and WT mice
were examined for expression of CD103 and CD11b, with the numbers representing the frequency of each population as a percentage of total mig. DCs.
Scatter plot shows absolute numbers of each mig. DC population in the MLNs of CCR2 / and WT mice. Data are representative of two independent
experiments with n¼3/4 per experiment *Po0.05, **Po0.005, Student’s t-test. (c) CD45.1þ /CD45.2þ WT mice were lethally irradiated and
reconstituted with a 50:50 mix of bone marrow (BM) from CD45.1þ WT and CD45.2þ CCR2 / mice. Chimerism among the populations of
CD11cþMHCIIþ MPs from SI LP was assessed 8 weeks later. (d) Ratio of CD45.1WT:CD45.2 CCR2 / -derived cells among CD11cþMHCIIþ MPs
and eosinophils from SI LP, blood Ly6Chi monocytes (mo), and migratory DCs in the MLNs of chimeric mice. ***Po0.001 vs. macrophages (mfs), one-
way analysis of variance (ANOVA) with Bonferroni posttest. Data are representative of two independent experiments with n¼ 3 per experiment.
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DCs in this respect (Figure 5b). However, the CCR2þ
CD103CD11bþ DCs were more effective than the other
subsets at driving the differentiation of helper type 17
(Th17) cells in vitro (Figure 5c). Notably, this property
within the CD103CD11bþ DCs was masked when they were
compared with other subsets as a single population (data not
shown).
Efficient generation of Th17 cells by the CCR2þ subset of
CD103CD11bþ DCs is associated with higher frequency
of IL-12/IL23p40 producing cells
In an attempt to understand why CCR2þCD103CD11bþ
DCs were effective in priming Th17 cells, we examined their
production of Th17-polarizing cytokines. Intracellular cyto-
kine staining showed that there were ample proportions of
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Figure 4 CCR2 expression defines two populations of intestinal CD103CD11bþ dendritic cells (DCs). (a) Representative CCR2 staining on
CD11cþMHCIIþCD64 DC populations from small intestinal lamina propria (SI LP) of wild-type (WT) mice, compared with total DCs from CCR2 /
mice as a control. The scatter plot shows the proportion of CCR2þ cells in each SI LP DC population as a percentage of total CD11cþMHCIIþCD64
cells, with each point representing amouse and the horizontal line representing themean.Data are representative of three independent experiments with
n¼4 per experiment. (b) Representative CCR2 staining on CD103CD11bþ DCs among endogenous (CD11cþMHCIIþCD64 ) and donor-derived
(Violetþ , CD45.2þ , CD11cþ , MHCIIþ ) cells in the SI LP 5 days after transfer of CD45.2þ DC precursors (pre-DCs) into unmanipulated CD45.1þ WT
recipients. (c) Quantitative PCR (Q-PCR) analysis of mRNA for Zbtb46, Flt3, and Ccr7 by CCR2þ and CCR2 subsets of CD103CD11bþ DCs
fluorescence-activated cell sorter (FACS)-purified from the SI LP of WT mice, compared with CD103þ DC subsets and CD64þ macrophages (mfs).
Data are fromasingle experimentwith 10mice pooled and are expressed relative toHPRTusing the 2DDctmethodwithmfs set to 1. (d) Representative
CCR2 staining on subsets of DCs amongCD11cþMHCIIhi migratory (Mig.) DCs in wild-typemesenteric lymph nodes (MLNs), and in total migratory DCs
from CCR2 / mice used as a control. Scatter plot shows the proportion of CCR2þ cells in each SI LP DC population among total
CD11cþMHCIIþCD64 cells, with each point representing a mouse and the horizontal line representing the mean. Data are representative of two
independent experiments with n¼ 4 per experiment.
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Figure 5 CCR2-expressing CD103CD11bþ intestinal dendritic cells (DCs) drive T helper type 17 (Th17) responses. 3 104 Fluorescence-activated
cell sorter (FACS)-purified DC subsets from small intestinal lamina propria (SI LP) were pulsed with 2mgml 1 ovalbumin (OVA) protein and cocultured
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CCR2þCD103CD11bþ DCs. Data are representative of one or two independent experiments with n¼ 3/4 per experiment.
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IL-6-producing cells among all DC subsets under steady-state
conditions and, if anything, these were slightly lower for
the CCR2þCD103CD11bþ DCs than the CCR2CD103
CD11bþ or CD103þCD11bþ subsets (Figure 5d and data not
shown). However, the CCR2þCD103CD11bþ population
was the only one in SI LP to contain IL-12/IL-23p40-producing
DCs under steady-state conditions, as well as showing the most
robust increase in the frequency of IL-12/IL-23p40-producing
cells in response toToll-like receptor 4 stimulation.Under these
conditions, B30% IL-12/IL-23p40þ DCs were found within
this subset, compared withB10% in other subsets (Figure 5e).
Toll-like receptor 4 stimulation had no effect on the already
high frequencies of IL-6-producing cells among any subset
(Figure 5d). Given that the CCR2-expressing CD103
CD11bþ DCs did not show any difference in their ability
to prime Th1 responses, these findings indicate that their
preferential effect on Th17 cells may be explained most readily
by an enhanced ability to produce IL-23.
CCR2þCD103CD11bþ LP DCs both express and are
dependent on the transcription factor IRF4
A defining feature of the CD11bþ lineage of conventional DCs
in mice is dependence on the interferon regulatory factor 4
(IRF4) transcription factor for their development,22,25,36–39 and
we and others have shown recently that lack of IRF4 expression
in CD11cþ cells leads to a selective defect in CD103þCD11bþ
intestinal DCs that correlates with impaired Th17 responses
in vivo.22,36 As these results appear to contrast with our
discovery of a CCR2þ subset of CD103CD11bþ DCs that is
more efficient in inducing Th17 cell differentiation than the
other subsets, we thought it important to assess how IRF4might
control their development. Similar to CD103þCD11bþ DCs
in LP, both the CCR2þ and CCR2 subsets of CD103
CD11bþ DCs expressed IRF4, but not IRF8 (Figure 6a).
Conversely, and as expected, the CD103þCD11b DCs
showed the opposite pattern, expressing IRF8, but not IRF4
(Figure 6a). As we found previously, CD11c-cre x IRF4fl/þ
mice had a substantial decrease in the numbers and proportions
of CD103þCD11bþ DCs in SI LP and, interestingly, these
animals also showed a significant defect in theCCR2þ subset of
CD103CD11bþ DCs (Figure 6b). In contrast, CD103þ
CD11b and CCR2CD103CD11bþ DCs were unaffected
inCD11c-cre IRF4fl/þ LP. Thus, the loss of CCR2þCD103
CD11bþ DCs may contribute to the defective Th17 cell
generation in these mice.
Putative CCR2-expressing CD103 DC equivalents in the
human intestine
Having identified CCR2þCD103CD11bþ DCs in the
murine intestine, we next sought to determine whether
equivalent cells were present in the human intestinal LP. By
excludingCD14þCD64þ cells that representmfs,24DCswere
readily identifiable in human colonic LP among live CD45þ
CD11cþHLA-DRþ cells (Figure 7). As in mouse LP, exami-
nation of CD103 and SIRPa expression identified three distinct
populations of human DC populations and the CD103
SIRPaþ DCs were heterogeneous for CCR2 expression
(Figure 7). Thus, the CCR2-based heterogeneity of
CD103 mucosal DCs is maintained across species.
DISCUSSION
The nature and origins of intestinal DCs have been contentious
for several years. Although the presence of two CD103þ DC
subsets based on CD11b expression has been recognized for
some time and they are generally accepted to be conventional
DCs,3,17,19,20,40–42 the existence of genuine CD103 DCs
among CD11cþMHCIIþ MPs has been less certain. Initially
considered to be proinflammatory ‘‘DCs’’,19,20,43 later studies
definedCD103CD11bþ MPs asmfs, on the assumption that
CD103 and CX3CR1 were mutually exclusive markers of DCs
and mfs, respectively.3 Here, we demonstrate that more
rigorous strategies reveal heterogeneity within this population
in the steady-state intestine. In addition to confirming recent
findings that the majority of CD103CD11bþ express the mf
markers CD64 and F4/80,16,22,24,44 we show definitively that a
population of CD64CD103CD11bþ DCs is present in
steady-state LP. A similar subset can be found in pseudoafferent
intestinal lymph.44 Similar to their CD103þ counterparts, the
CD103CD11bþ DCs in LP expressed Zbtb46,26,27 as well as
CD26 and CD272, markers identified by the Immunological
Genome Consortium as being specific to DCs.11 Conversely,
they lacked the mf-restricted markers CD14 andMerTK,9 and
showed poor phagocytic activity compared with CD64þ mfs.
Importantly, the CD64CD103 DCs expressed Flt3 and
were virtually absent in the LP of Flt3L / mice. The
CD103CD11bþ DCs also had a short half-life in vivo and
showed evidence of proliferation in situ, properties identical to
DCs in other peripheral tissues25 and to their CD103þ
counterparts in the SI LP. In stark contrast, CD64þCD103
CD11bþ mfs were long-lived and noncycling.
Our studies using adoptively transferred precursors under-
lined the heterogeneity of intestinal CD103 MPs, by
demonstrating that CD103CD11bþ intestinal DCs derived
from DC-committed precursors. This contrasts with previous
reports that concluded that CD103 ‘‘DCs’’ were derived from
Ly6Chi monocytes. However, these studies used less precise
phenotyping strategies and used intense depletion of endo-
genous myeloid cells that may alter the fate of donor cells and
their progeny.19–21,23 In our hands, Ly6Chi monocytes were
unable to generate CD103CD11bþ DCs and gave rise only to
F4/80þ mfs in healthymucosa. Becausewewere limited by the
numbers ofmonocytes available for transfer, we cannot exclude
the possibility that some genuine DCs might arise if there is
expanded entry of monocytes into the mucosa. However, our
studies suggest that this is likely to be a rare event under steady-
state conditions. In contrast, pre-DCs could clearly give rise to
all populations of DCs, including the novel CCR2þCD103
CD11bþ subset we identified. Whether these distinct subsets
arise from the same or multiple subsets of these progenitors
remains unclear. A recent study has suggested that b7 integrin-
expressing DC precursors had a preferential ability to
repopulate mucosal CD103þ DCs,45 but it is currently unclear
how these ‘‘pre-mucosal’’ DCs relate to the pre-DCs used here
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and in other studies.34,45 Although our transferred pre-DCs
lacked the B220 expression reported on the ‘‘pre-mucosal’’
DCs, a proportion were b7þ (our unpublished observations)
and therefore some progenitors with selective gut-homing
properties may be present in our populations. How these b7þ
precursors specifically contribute to intestinal DC populations
remains to be investigated. The idea that there might be
independent precursors of each DC subset could explain why
the proportions of donor-derived DCs in the intestine did not
always mimic those found among host DCs at different times
after transfer, as each lineage may develop at different rates.
Alternatively, these time-dependent differences might reflect
developmental relationships within the same lineage and these
issues will be the subject of future investigations.
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At first sight, our conclusions that all mucosal DCs derive
from pre-DCs appear to contradict a recent study by Zigmond
et al.,23 in which a population of mucosal Ly6CloCD11bþ
Zbtb46þ cells, likely to comprise our CD103 DCs, was
depleted by in vivo administration of anti-CCR2 antibody. As a
result, it was concluded that these DCs were derived from
CCR2-dependent Ly6Chi monocytes. An explanation for this
apparent discrepancy comes fromour discovery of a population
of pre-DC-derived, CCR2-expressing CD103CD11bþ
DCs that have all the properties of the other bona fide
DCs in LP and are found among migratory DC populations in
the MLNs. Importantly, CCR2-deficient mice displayed a
selective reduction in the numbers of CD103CD11bþ DCs
and this was intrinsic to the DCs, as it was replicated among
the progeny of CCR2 / BM in mixed WT:CCR2 / BM
chimeras.
Similar to CD103þ DCs, CD103CD11bþ DCs efficiently
induced the proliferation of antigen-specific CD4þ T cells after
antigen loading ex vivo. Significantly, the CCR2-expressing
CD103CD11bþ DCs induced the polarization of Th17 cells
in vitro, a function previously associated with CD103þ
CD11bþ DCs. This idea was based on evidence from mice
lacking IRF4, Notch-2, or human langerin in CD11cþ cells that
showed concomitant, selective defects in CD103þCD11bþ
DCs and Th17 cells in the intestine.22,36,46,47 Importantly, our
novel population of Th17-inducing, CCR2þCD103CD11bþ
DCs expressed IRF4 and their numbers were reduced in
CD11c-cre-IRF4fl mice, suggesting that this previously unrec-
ognized subset could contribute to the impairment of Th17 cell
generation in these animals. Indeed, a very recent study has
demonstrated that the role of CD103þCD11bþ DCs in Th17
cell homeostasis in the LP may be to act as an accessory cell,
rather than to interact with T cells in a cognate manner.47 More
work is clearly warranted to explore how these various subsets
of DCs may cooperate in the priming of T-cell responses
in vivo. The presence of apparently intrinsically proinflam-
matory cells among the CD103 DC population could also
help explain why CD103 ‘‘DCs’’ were often previously
associated with inflammation when less well-defined cell
populations were used.43,48 Finally, it should be noted that
CD103CD11bþ DCs have been shown to drive Th17
polarization in other tissues such as the lung.22 As the
expression of CD103 by CD11bþ DCs is unique to the
intestine, it remains possible that the Th17-polarizing CCR2þ
CD103CD11bþ DCs we have identified are intermediate
stages within the development of CD103þCD11bþ DCs,
whose ultimate differentiation involves the loss of CCR2 and
acquisition of CD103, perhaps following their conditioning by
the intestinal microenvironment.49
Although previous studies have correlated the ability of
intestinal DCs to prime Th17 cells with their production of
IL-6,36 we found similar frequencies of IL-6-producing cells
among CCR2 and CCR2þCD103 DCs. However, the
CCR2-expressing DCs included more cells containing intra-
cellular IL-12/IL-23p40, both in steady state and even more
markedly after Toll-like receptor 4 ligation in vitro. As there
were no differences in the ability of the various subsets of
CD103CD11bþ DCs to prime Th1 responses in vitro, we
propose that the increased levels of IL-12/IL-23p40 in the
CCR2-expressing CD103CD11bþ DCs reflect enhanced
production of IL-23 and that this explains their Th17-polarizing
properties. However, the difficulties associated with obtaining
high numbers of DCs when cultured alone, together with the
current lack of a mouse model that lacks CCR2þCD103
CD11bþ DCs specifically, mean that further work is required
to confirm this hypothesis directly.
The potential clinical implications of our results are
highlighted by our finding of similar heterogeneity of CCR2
expression among CD103 SIRPaþ DCs in steady-state
human intestine, a population that appears to be equivalent to
CD103CD11bþ DCs in mice.22 It will be of interest to
examine the function of this subset particularly in disorders
associated with Th17 cells such as Crohn’s disease. Further-
more, our results showing that CCR2 dependence is not a
reliable indicator of monocytic origin and that DCs and mfs
are truly derived fromdistinct precursors raise important issues
that need to be considered in the clinical situations where
monocyte-derived cells and myeloid cell growth factors are
being trialed.
In conclusion, we show definitively that CD103CD11bþ
MPs in the murine intestinal LP include a population of
genuine DCs that are derived exclusively from DC-committed
precursors, rather than Ly6Chi monocytes as previously
assumed. This subset of DCs is itself heterogeneous, containing
a population of CCR2-expressing DCs with proinflammatory
properties. These results provide novel insights that may help
explain recent discrepancies on the origins and nature of
CD103CD11bþ MPs. An analogous subset is present in
human intestine, indicating that this heterogeneity of DCs may
be relevant across species barriers.
METHODS
Mice and human tissues. WT C57Bl/6 (B6) mice were purchased
from Harlan Olac (Bicester, UK). CX3CR1þ /gfp mice50 and C57Bl/
6.SJL (CD45.1þ ) mice were bred originally at Lund University (Lund,
Sweden). CCR2 / mice51 mice were obtained from Professor R.
Nibbs (University of Glasgow, Glasgow, UK). OTII mice were bred in-
house. All these strains were maintained at the University of Glasgow
animal facilities. Flt3L / ,52 CD11c-cre IRF4floxed mice,36 and
C57Bl/6 WT mice were bred and maintained at the VIB Ghent
University (Ghent, Belgium). CD11c-cre IRF4floxed mice were also
bred andmaintained at LundUniversity. Allmicewere backcrossed for
at least 9 generations on to the B6 background, maintained under
specific pathogen-free conditions, and were used between 6 and 12
weeks of age. Animal experiments were performed in accordance with
UK Home Office guidelines.
Histologically normal samples of human colon were obtained from
patients undergoing surgical resections for adenocarcinoma. Tissues
were obtained with informed consent and experiments performed in
accordance with the NHS Greater Glasgow and Clyde (NHS GGC)
Bio-repository ethics application number 65.
Murinecell isolation. LP cells were obtained frommurine intestines by
enzymatic digestion as described previously.5,28 Cells were isolated
from MLNs by enzymatic digestion with 1mgml 1 collagenase D
(Roche Diagnostics GmbH, Mannheim, Germany) in calcium
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magnesium free (CMF) Hank’s balanced salt solution (HBSS; Gibco,
Invitrogen, Paisley, UK) for 45min. After isolation, cells were passed
through a 100 mm and a 40 mm filter before use (Corning Scientific
Laboratory Supplies, Coatbridge, UK).
Humancell isolation. Underlying fat andmuscle layers were removed,
tissue was washed in CMF HBSS 2% fetal calf serum (Sigma, Poole,
UK), and cut into 0.5 cm sections. The tissue was then shaken vig-
orously in 10ml HBSS/2% fetal calf serum and the supernatant
discarded. To remove the epithelial layer, 10ml fresh CMF HBSS
containing 2mMEDTA (Sigma) was added, and the tube was placed in
a shaking incubator for 15mins at 37 1C before being shaken vig-
orously, and the supernatant was discarded. The intestinal tissue was
washed in CMF HBSS and the EDTA step repeated twice more. The
remaining tissue was digested with prewarmed complete RPMI-1640
supplemented with 2mM L-glutamine, 100 mgml 1 penicillin,
100 mgml 1 streptomycin, 1.25 mgml 1 Fungizone (all from Gibco,
Invitrogen), and 10% fetal calf serum containing collagenase VIII
(1mgml 1, Sigma), Collagenase D (1.25mgml 1, Roche), Dispase
(1mgml 1, Gibco, Invitrogen), and DNase (30 mgml 1, Roche) for
45min in a shaking incubator at 37 1C. The resulting cell suspension
was removed and the digestion was repeated until all tissues were
dispersed. Cell suspensions were passed through a 40 mm cell strainer
(BD Biosciences, Oxford, UK), washed twice in complete RPMI, and
kept on ice until use.
Flow cytometric analysis and sorting. Cells were stained at 4 1C in
the dark as described previously28 using the antibodies listed in
Supplementary Experimental Procedures online. For intracellular
cytokine staining, whole LP digests were incubated for 4.5 h with
5 mgml 1 brefeldin A and 2 mM monensin (both from Biolegend,
London, UK) in the presence or absence of 100 ng lipopolysaccharide
from Salmonella typhimurium (Sigma) before fixation and per-
meabilization. In all analyses, following doublet exclusion, live cells
were identified using 7-AAD (Biolegend) or fixable viability dye
(eBioscience, Hatfield, UK). Data were acquired on an LSR II, Fortessa,
FACSAria I or FACSAria III (BD Biosciences) and analyzed using
FlowJo software (Tree Star, Ashland, OR).
Adoptive transfer of BM precursors. For pre-DCs, WT mice were
injected with 2 106 flt3L-secreting B16 tumor cells subcutaneously
(a kind gift from Dr Oliver Pabst, Hannover, Germany) and 10–14
days later BM was isolated and RBC lysed (Stem Cell Technologies,
Grenoble, France). Cells were labeled with eFluor450 CellTrace Violet
proliferation dye (eBioscience) and pre-DCs identified as Lin
CD11cintCCR9B220loCD135þ cells. Next, 7 105 FACS sorted pre-
DCs were injected into unmanipulated congenic recipients, or into
mice that had received 1.2%DSS ad libitum in the drinking water for 3
days before transfer. For monocyte transfers, 1 106 FACS-purified
Ly6Chi monocytes (CD11bþCD117Ly6GLy6ChiCX3CR1int)
from the BM of CX3CR1þ /gfp CD45.1þ /CD45.2þ mice were
transferred into CD45.2 CCR2 / mice.
Antigen-specific T-cell proliferation in vitro. DC subsets were FACS-
purified and pulsed with 2mgml 1 ovalbumin (Grade VI, Sigma)
for 2 h before being washed extensively and cocultured for 4 days
with carboxyfluorescein succinimidyl ester-labeled, naive
CD62LhiCD25CD4þ T cells FACS-purified from the lymph nodes
of OTII mice. For intracellular cytokine staining, cultured cells were
placed in a stimulation cocktail (eBioscience) containing phorbol
myristate acetate, ionomycin, brefeldin A, and monensin for 4.5 h
before fixation, permeabilization, and staining with antibodies against
IL-17a, interferon-g, and FoxP3.
Quantitation of gene expression by real-time reverse-transcription
PCR. Total RNA was purified from sorted LP cells using the
RNeasy Micro kit (Qiagen, Manchester, UK). RNA was reverse
transcribed to complementary DNA and gene expression was assayed
by quantitative reverse-transcription PCR as described previously.16
The primer sequences used are detailed in Supplementary Experi-
mental Procedures online.
Generation of WT:CCR2 / mixed BM chimeras. CD45.1/CD45.2
WTmice received two doses of 5Gy, 2 h apart, before receiving 5 106
BM cells intravenously from CD45.1 WT and CD45.2 CCR2 / BM
in a 50:50 ratio. Chimerism was assessed 8 weeks after reconstitution.
Assessment of phagocytosis. 3 106 Cells were assessed for
phagocytosis of pHrodo Escherichia coli bioparticles (Molecular
Probes, Life Technologies, Paisley, UK) according to the manu-
facturer’s guidelines and analyzed by flow cytometry.
Assessment of BrdU incorporation in vivo. Mice were injected once
intraperitoneally with 1mg BrdU (BD Biosciences) and in some
experiments received 0.8mgml 1 BrdU (Sigma) in their drinking
water for 3 days. The incorporation of BrdU by isolated cells was
assessed using the BD BrdU Flow kit (BD Biosciences).
Statistical analysis. Results are presented as means ±1 s.d. unless
otherwise stated and groupswere compared using Student’s t-test or, for
multiple groups, one-way analysis of variance followed by Bonferroni
posttest using Prism Software (GraphPad Software, San Diego, CA).
Supplementary Material is linked to the online version of the paper at
http://www.nature.com/mi
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